Many enterprise teams have already deployed LLMs in production. However, for enterprise AI teams, the biggest hurdle to deploying production-ready Generative AI products remains the fear of model hallucinations. Discover Galileo's LLM Hallucination Index
The latest from our portfolio companies.
AI21 Labs' vision for reliable enterprise AI has been boosted by further funding from Intel Capital and Comcast Ventures.
Artera's multi-modal AI test has been successfully validated for advanced prostate cancer. In collaboration with the UCL Cancer Institute, Artera validated its model on various trials, and have shown that it can effectively prognosticate patient outcomes.
Combining experimental and computational tools, Peptone is targeting disordered regions of proteins previously thought to be undruggable.
Generative AI tools are on the rise. For LLMs to provide value, they must be able to operate on all data. Today’s policies dictate what data can and cannot be shared. While such regulations are critical to protect our privacy, it creates enormous friction.
We’re thrilled to announce the completion of a successful Series C funding round of $155 million at a valuation of $1.4 billion, marking a major milestone AI21 Labs journey to bring reliable AI to the enterprise.
Ingonyama presents their ZK movie for a general audience. The company is not just navigating today’s challenges but preparing for a future in which Zero-Knowledge is a cornerstone of our online interactions.
New AHA president Joseph Wu (Greenstone Bio) is a pioneering scientist with an adventurous backstory.
Revolutionizing Industrial Inspection with its Four-Legged Robotic Workforce.
ANYbotics Secures $50M Series B Funding to Revolutionize Industrial Inspection with its Four-Legged Robotic Workforce
Walden Catalyst Ventures leads investment round to support high-volume operations
AI21 Labs partners with Amazon to offer top-performing, easily accessible foundation models
With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease
Enhancing the Writing Experience for Hundreds of Millions of People Around the World
Who will be the next health tech success story?
Artera Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI
Wordtune Spices: AI21 Labs intros an AI writing assistant that cites its sources
Our New Investment in Galileo
Our New Investment in Opaque Systems
Our New Investment in Peptone
Our New Investment in Voltron Data
Portfolio News: Our Investment in MindsDB.
Portfolio News: Our investment in Voltron Data